Clinical Trials Browser

Withdrawn × INDUSTRY × ER+ and AR+ Breast Cancer × Clear all

NCT02746328 2024-02-26

Add-on Study for Protocol G200802 (NCT02463032): Effect of GTx-024 on Maximal Neuromuscular Function and Lean Body Mass

Phase 2 Withdrawn

ER+ and AR+ Breast Cancer